WELL Health Technologies Corp.
WELL.TO
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 25.78% | 48.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 25.78% | 48.46% | |||
| Cost of Revenue | 16.22% | 13.30% | |||
| Gross Profit | 40.17% | 178.39% | |||
| SG&A Expenses | 29.79% | 10.45% | |||
| Depreciation & Amortization | 34.77% | -9.06% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.65% | 10.55% | |||
| Operating Income | 126.56% | 120.18% | |||
| Income Before Tax | 155.15% | 17.19% | |||
| Income Tax Expenses | 599.93% | 93.71% | |||
| Earnings from Continuing Operations | 142.10% | -28.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -7.25% | -124.42% | |||
| Net Income | 127.06% | -249.36% | |||
| EBIT | 126.56% | 120.18% | |||
| EBITDA | 68.95% | 159.09% | |||
| EPS Basic | 126.77% | -212.29% | |||
| Normalized Basic EPS | 142.13% | 82.88% | |||
| EPS Diluted | 126.21% | -171.87% | |||
| Normalized Diluted EPS | 141.62% | 82.88% | |||
| Average Basic Shares Outstanding | 1.03% | 11.92% | |||
| Average Diluted Shares Outstanding | 2.75% | 11.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||